FDA panel recommends approval of NeuroPace's anti-epilepsy implant

February 22, 2013 by Ingrid Mezo

NeuroPace makes progress in its years-long road to FDA approval with near-unanimous approval for its RNS neurostimulation therapy for epileptic seizures.


California neurostimulation devices maker NeuroPace crept 1 step closer to an FDA win for its epilepsy implant with near-unanimous approval from the FDA's Neurological Devices Advisory Panel.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.